Autolus Therapeutics's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Autolus Therapeutics (NASDAQ:AUTL) is scheduled to release its quarterly earnings report on March 14, 2024, with an expected EPS of $-0.25. Investors are hopeful for a beat on this estimate and positive future guidance. Despite a miss in the last quarter's EPS by $0.01, the stock price increased by 20.65% the following day. Historically, the company's stock performance has been positive, with a 150.47% increase over the last 52 weeks. Shares were trading at $5.39 as of March 12.
March 13, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Autolus Therapeutics is expected to report an EPS of $-0.25 for the upcoming quarter, with investors looking forward to positive guidance. The stock has seen a significant increase of 150.47% over the past year.
Given the historical performance where Autolus Therapeutics' stock price increased despite an EPS miss last quarter, and considering the significant annual stock price increase, there is a positive sentiment among investors. This optimism, coupled with the anticipation of positive future guidance, suggests a likely short-term positive impact on AUTL's stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100